Polymicrobial Assay
Polymicrobial Assay - Related Videos
03:57
An Assay to Determine Polymicrobial Biofilm Initiation on Virus-Infected Cells
0 Views •
2025
This video illustrates the initiation of polymicrobial biofilm formation on virus-infected cells by bacteria and fungi. Herpes simplex virus infection impedes bacterial attachment to the cells, preventing bacterial-fungal co-localization. In contrast, uninfected cells display bacterial-fungal co-localization and initiation of biofilm formation.
14:54
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
0 Views •
Cited by 16 •
2019
This protocol provides the necessary steps to establish and evaluate neonatal sepsis in 7-day-old mice.
07:16
Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
0 Views •
Cited by 3 •
2024
This methodology allows for the establishment of a polymicrobial biofilm model in cystic fibrosis for antimicrobial sensitivity testing in research and clinical laboratories. This model provides accurate and reliable results over a range of outputs.
03:53
Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
0 Views •
Cited by 3 •
2024
This protocol describes a cystic fibrosis (CF) lung-relevant four-species polymicrobial biofilm model that can be used to explore the impact of bacterial interspecies interactions.
06:45
Colon Ascendens Stent Peritonitis (CASP) - a Standardized Model for Polymicrobial Abdominal Sepsis
0 Views •
Cited by 44 •
2010
The Colon Ascendens Stent Peritonitis (CASP) is a highly standardized model for polymicrobial abdominal sepsis in rodents. This article describes the surgical procedure of CASP. The CASP model and its variants allow the systematic investigation of various problems concerning the subject of sepsis.
FAQs
Species may compete for shared resources, cooperate in ways that support persistence, or alter one another’s growth and virulence. These interactions can change as environmental conditions shift, so the behavior of one organism may not predict its behavior alongside others. Measuring the combined response helps reveal community-level effects that single-species experiments can miss.
Environmental conditions influence which organisms grow, persist, or affect one another within the assay. Changes in available resources or other relevant conditions can shift the balance between competition and cooperation, producing different effects on viability, virulence, or host responses. Controlling and documenting these conditions is therefore important when interpreting microbial community behavior.
A single-organism test isolates the behavior of one microbe, whereas a polymicrobial assay examines outcomes generated by several organisms acting together. The multi-species format can expose interactions that alter growth, treatment sensitivity, virulence, or inflammation. This comparison helps researchers determine whether findings from simplified systems remain relevant to more complex infections.
A useful workflow begins by bringing the selected microbial species together under defined experimental conditions, then evaluating the outcomes relevant to the research question. Researchers can examine growth or viability, assess virulence-related effects, and measure host immune responses when a host component is included. Comparing these findings with simpler test systems can identify interaction-dependent effects.
Common readouts include microbial growth, viability, virulence, and host immune responses. Together, these measurements show whether species interactions change community persistence, disease-related activity, or the intensity of inflammation. In infection studies, the results can also indicate whether an antimicrobial strategy or host-directed therapy performs differently in a multi-species setting.
These assays help investigate how microbial communities influence inflammation and disease progression rather than focusing only on isolated organisms. They also support evaluation of antimicrobial strategies and host-directed therapies under conditions that better reflect complex infections. Such findings can clarify why treatment sensitivity or immune effects differ when multiple microbial species are present.